Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
filingDate |
2002-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2004-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2004537543-A |
titleOfInvention |
Mycoplasma hyopneumoniae vaccine and method for reducing mycoplasma bovis in cattle |
abstract |
The present invention provides a method for treating or treating a disease or disorder in an animal caused by infection with Mycoplasma bovis (M. bovis) by administering to the animal an effective amount of Mycoplasma hyopneumoniae (M. bovis) vaccine. How to prevent. M. The hyo vaccine may be an inactivated or modified live vaccine preparation consisting of whole or part cells, a subunit vaccine or a nucleic acid or DNA vaccine. M. g. Administered according to the present invention. Hio vaccines can be synthesized or produced recombinantly. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180074804-A |
priorityDate |
2001-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |